Mood Stabilizers Should be combined with other drugs to work effectively Effective against acute mania if combined with atypical anti-psychotics |
|||||
|
Mode of Action
|
Benefits
|
Drawbacks
|
Notes
|
|
lithium
|
not well studied, is supposed to decrease norepinephrine release and serotonin synthesis |
effectively lessens both mania and depression symptoms; may have anti-suicide effect |
not used for acute mania, since it needs time to offer benefits;
high risk of overdose
|
first-line treatment for mania
|
|
Anticonvulsants
|
|
|
|
|
|
valporate
carbamazepine
|
increases GABA levels in the brain; positively influences brain cells membranes
blocks sodium channels making brain cells less excitable
|
works well for acute mania due to rapid onset of action
effective for rapid cycling
|
may cause liver damage, decreased platelet count, inflammation of the pancreas may rarely cause low white blood cells count, fatal skin conditions, and psychosis |
First-line treatment of manic symptoms
|
|
Calcium Channel Blockers
|
originally used for cardiovascular disorders
|
comparatively safe to be used in pregnant women
|
are not well studied for the use in bipolar disorder
|
third-line choice for mood stabilizing
|
|
verapamil
nimodipine
|
blocking calcium channels results in the mood stabilizing
|
helpful in mania
easily enters the brain, helpful in rapid cycling
|
is difficult to enter the brain
more research is needed
|
immediate-release verapamil is more effective
|
|
Antidepressants
May cause mania episodes Should be used in combination either with mood stabilizers or antipsychotics Used to lessen depressive phase symptoms |
|||||
|
Mode of Action
|
Benefits
|
Drawbacks
|
Notes
|
|
SSRIs
|
increase serotonin levels in the brain without affecting other neurotransmitters |
seldom associated with the aggravation of manic symptoms, side effects subside with time |
may cause serotonin syndrome
|
should not be used with MAOIs in view of sever side effects |
|
fluvoxamine
|
has stimulating effects
neither stimulating nor sedating
sedating
neither stimulates nor sedates
|
has low risks of withdrawal symptoms
has fewer reports on convulsions
is commonly well-tolerated
is not associated with convulsions
has the lowest rate of side effects, fewer drug interactions
|
nausea is frequent,
has the longest onset of action
nausea is the most common side effect, high risk of weight gain
more sedating than the others
|
the first FDA approved SSRI antidepressant
can increase the risk of self-harm in children
|
|
Tricyclics
desipramine
nortriptyline
protriptyline
dopexin
imipramine
|
affect the levels of such neurotransmitters in the brain as serotonin and norepinephrine, thus are nonselective |
very effective against depressive episodes of bipolar disorder |
have high risks of switching to mania episodes, overdose can be fatal |
have a long history of use as antidepressants
|
|
MAOIs
phenelzine
tranilcypromine
|
inhibit monoamine oxidase in the brain increasing the levels of serotonin, norepinephrine and dopamine |
effectively reduce depression symptoms, side effects subside with time |
associated with numerous drug interactions
|
treatment is inconvenient due to multiple restrictions in the diet |
|
Other
bupropion
|
inhibits neurotransmitter dopamine
lower doses increase serotonin levels, higher ones raise norepinephrine |
has low potency of switching to mania, weight gain, and sexual dysfunction
efficacy is dose-related, non-responsive to other drugs patients may benefit from it |
can cause seizures
high doses may cause hypertension
|
good for severe depressive phase
|
|
Antipsychotics
Used to treat bipolar disorder with psychotic features |
|||||
|
Mode of Action
|
Benefits
|
Drawbacks
|
Notes
|
|
Typical
fluphenazine
haloperidol
thioridasine
molindone
|
affecting many neurochemical systems, blockage of dopamine receptors is the main action of antipsychotics |
as effective against mania as lithium, may be used on a long-term basis with mood stabilizers |
have many side effects, the most troublesome being movement disorder (e.g. parkinsonism) |
have long history of use against mania
|
|
Atypical
|
affect dopamine and serotonin receptors, exact action is unknown |
have lower risks of causing movement disorder side effects
|
have many potentially dangerous adverse reactions
|
newer drugs on the market
|
|
clozapine
risperidone
olanzapine
|
binds to serotonergic and dopamine receptors in the brain
a strong dopamine antagonist, partially affects serotonin receptors
mainly affects serotonin levels
|
effective for both manic and depressive phases and rapid cycling
effective for both phases of the disorder
works well for eliminating acute mania symptoms
|
may cause decrease in the white blood cells count, seizures, and weight gain is not associated with weight gain, may rarely aggravate mania weight gain, diabetes, hyperlipidemia are frequent side effects |
the first member of new drugs generation
approved for eliminating depressive symptoms
|
|
Benzodiazepines
Studied to be used in acute mania
Rarely used alone
May be stopped as soon as a patient becomes stable Have rapid onset of action |
|||||
|
Mode of Action
|
Benefits
|
Drawbacks
|
Notes
|
|
clonazepam
lorazepam
|
many-fold action on GABA and benzodiazepine receptor
has sedating, tranquilizing, and hypnotic effects
|
helpful in relieving acute mania
rectal and intramuscular administration is possible
|
has many side effects, habit-forming
high risks of tolerance, dependence, and withdrawal symptoms
|
benzos overdose is dangerous
|
Tip for you : Sign-in with Your OpenID and post faster, easier and with easy access to all your past posts. | |
Your Nick: |